As for lipid metabolism pathways, targeted inhibition of lipogenic enzymes abolished expression of CD44, a transmembrane protein associated with metastases in several cancers including CRC, as well as attenuated the activation of MET, Akt, FAK, and paxillin, known to regulate adhesion, migration, and invasion. This evidence concerns the gene CD44 and colorectal carcinoma.